Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book
  1. Brieflands
  2. journals
  3. Journal of Reports in Pharmaceutical Sciences
  4. Articles

  5. Study of Oxidative Stress and Apoptotic Genes in SW480 Cell Lines Treated with Selenium Nanoparticles
  6. Scopus by Title (Ref)

Journal of Reports in Pharmaceutical Sciences

homeHome
play_arrowCurrent IssuelistAll Issuespicture_as_pdfIn Presscheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
infoJournal InformationgroupsEditors & BoardspublicIndexing and Listing Sourcesbar_chartJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Publication Malpractice Statementassignment_indReviewer and AE Registration FormemailSupportphoneContact Us
euroAPCcampaignAnnouncement of New Publisher
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Biosynthesis of selenium nanoparticles by Aloe vera leaf extract and its biomedical applications

- El-Ebidy A.M. , et al.

2. Selenium-induced redox imbalance triggers oxidative DNA damage and the p53-dependent apoptosis of CHL-1 human melanoma cells

- Alhawamdeh M. , et al.

HomeInstructionsAPCAnnouncement of New Publisher

Articles

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts
  • Search

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Publication Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.